Peter García

Pete Garcia is a seasoned finance professional with extensive experience serving as Chief Financial Officer in various biotechnology and pharmaceutical companies. Pete is currently a Member of the Board of Directors at DURECT Corporation, ALX Oncology, and MORAGA BIOTECHNOLOGY CORPORATION. Pete has a background in finance, accounting, and corporate governance, with a strong track record of managing financial operations and securing investments in the healthcare industry. Pete holds an MBA in Finance from UCLA Anderson School of Management and a BA in Economics from Stanford University.